There's a push to prevent pediatric cancer drug shortages resulting in the rationing of doses, and in some cases delayed treatment for cancer patients nationwide. "We can't expect the industry to police itself. We need Congress to step in," said Roswell Pediatric Oncology Chair, Dr. Kara Kelly.